Page last updated: 2024-09-04

moxifloxacin and rocuronium

moxifloxacin has been researched along with rocuronium in 2 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(rocuronium)
Trials
(rocuronium)
Recent Studies (post-2010) (rocuronium)
3,1575521,6902,1577661,077

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
de Kam, PJ; Peeters, P; Prohn, M; Thomsen, T; van Kuijk, J1

Trials

1 trial(s) available for moxifloxacin and rocuronium

ArticleYear
Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    Clinical drug investigation, 2010, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Androstanols; Arrhythmias, Cardiac; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; gamma-Cyclodextrins; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Moxifloxacin; Neuromuscular Nondepolarizing Agents; Quinolines; Risk Assessment; Risk Factors; Rocuronium; Sugammadex; Time Factors; Vecuronium Bromide; Young Adult

2010

Other Studies

1 other study(ies) available for moxifloxacin and rocuronium

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008